Ronald G. Jubin
Director Técnico/Científico/I+D en Prolong Pharmaceuticals LLC .
Perfil
Ronald G.
Jubin is currently the Vice President of Research & Development at Prolong Pharmaceuticals LLC since 2013.
Prior to this, he worked as a Principal at Schering-Plough Research Institute.
He holds a doctorate degree from New Jersey Medical School.
Cargos activos de Ronald G. Jubin
Empresas | Cargo | Inicio |
---|---|---|
Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Director Técnico/Científico/I+D | 18/12/2013 |
Antiguos cargos conocidos de Ronald G. Jubin.
Empresas | Cargo | Fin |
---|---|---|
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formación de Ronald G. Jubin.
New Jersey Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Ronald G. Jubin